Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative Hysteroscopy 02/25/2022 INTERVENTIONAL not-comparable 1,688.75 0 A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer 02/25/2022 INTERVENTIONAL not-comparable 1,688.75 0 Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer 02/25/2022 INTERVENTIONAL not-comparable 1,688.75 0 Factors Influencing Breast Cancer Resection Volumes And Their Impact on Treatment Outcome (FIBRATIO) 02/25/2022 OBSERVATIONAL not-comparable 1,688.75 0 Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes 02/28/2022 OBSERVATIONAL not-comparable 1,685.75 0 Breast Cancer Prevention and Screening Membership 02/28/2022 INTERVENTIONAL not-comparable 1,685.75 0 Time Restricted Eating During Chemotherapy for Breast Cancer 02/28/2022 INTERVENTIONAL not-comparable 1,685.75 0 Delivering Empowering Conversations About Obstetric Regional Anesthesia for Underserved Minorities 03/02/2022 INTERVENTIONAL not-comparable 1,683.75 0 A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years 03/02/2022 INTERVENTIONAL not-comparable 1,683.75 0 Uterine Transplant for Women With Absolute Uterine Factor Infertility (AUFI) 03/02/2022 INTERVENTIONAL not-comparable 1,683.75 0 The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World. 03/02/2022 OBSERVATIONAL not-comparable 1,683.75 0 The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets 03/04/2022 INTERVENTIONAL not-comparable 1,681.75 0 mHealth India Postnatal Health Intervention Effectiveness 03/07/2022 INTERVENTIONAL not-comparable 1,678.75 0 Organic Diet in Pregnancy and Risk Markers of Health Effects (The OrgDiet Project) 03/07/2022 INTERVENTIONAL not-comparable 1,678.75 0 CBT for Postpartum Depression and Infant Emotion Regulation 03/08/2022 INTERVENTIONAL not-comparable 1,677.75 0 Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer. 03/09/2022 INTERVENTIONAL not-comparable 1,676.75 0 Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer 03/14/2022 INTERVENTIONAL not-comparable 1,671.75 0 Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients 03/14/2022 INTERVENTIONAL not-comparable 1,671.75 0 Neurofeedback Based on Near-infrared Spectroscopy as a Therapy for Food Addiction in Obese Subjects. 03/14/2022 INTERVENTIONAL not-comparable 1,671.75 0 Functional Evaluation After Breast Reconstruction With a Minimally Invasive Latissimus Dorsi Flap Following Radical Surgery for Breast Cancer. 03/14/2022 INTERVENTIONAL not-comparable 1,671.75 0 Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation 03/15/2022 INTERVENTIONAL not-comparable 1,670.75 0 HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness 03/15/2022 OBSERVATIONAL not-comparable 1,670.75 0 Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) 03/16/2022 INTERVENTIONAL not-comparable 1,669.75 0 Examining the Effects of Estradiol on Neural and Molecular Response to Reward 03/16/2022 INTERVENTIONAL not-comparable 1,669.75 0 Effects of and Exploring the Processes of Free Movement Dance as a Physical Therapy Intervention for Female Patients Diagnosed With Chronic Widespread Pain (Including Fibromyalgia). 03/16/2022 INTERVENTIONAL not-comparable 1,669.75 0 Improving Diagnostics in Cervical Dysplasia 03/17/2022 INTERVENTIONAL not-comparable 1,668.75 0 The National Lipedema Study 03/17/2022 INTERVENTIONAL not-comparable 1,668.75 0 Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer 03/17/2022 INTERVENTIONAL not-comparable 1,668.75 0 Limited Ankle Dorsiflexion and Effect on Single Limb Squats in Individuals With Patellofemoral Pain 03/17/2022 INTERVENTIONAL not-comparable 1,668.75 0 Mobile Phone Messaging to Improve Reproductive Health for Women Living With HIV in Kenya (Mobile WACh Empower) 03/17/2022 INTERVENTIONAL not-comparable 1,668.75 0 Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants 03/18/2022 OBSERVATIONAL not-comparable 1,667.75 0 Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme 03/18/2022 INTERVENTIONAL not-comparable 1,667.75 0 The Efficacy of Aspirin Combined With Hydroxychloroquine Treatment in High Risk Pregnancies for Preeclampsia 03/18/2022 INTERVENTIONAL not-comparable 1,667.75 0 Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study 03/18/2022 INTERVENTIONAL not-comparable 1,667.75 0 Oxytocin Maintenance Infusion in Labouring Women Undergoing Cesarean Delivery: an Up-down Sequential Allocation Study 03/22/2022 INTERVENTIONAL not-comparable 1,663.75 0 Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System 03/22/2022 INTERVENTIONAL not-comparable 1,663.75 0 Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer 03/23/2022 INTERVENTIONAL not-comparable 1,662.75 0 Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions. 03/23/2022 INTERVENTIONAL not-comparable 1,662.75 0 Smart Bra for Diagnosing Breast Cancer 03/24/2022 INTERVENTIONAL not-comparable 1,661.75 0 Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer 03/25/2022 INTERVENTIONAL not-comparable 1,660.75 0 Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk 03/28/2022 INTERVENTIONAL not-comparable 1,657.75 0 Healthy Eating in Women at Risk of Gestational Diabetes 03/29/2022 INTERVENTIONAL not-comparable 1,656.75 0 Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal) 03/29/2022 OBSERVATIONAL not-comparable 1,656.75 0 A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection 03/29/2022 INTERVENTIONAL not-comparable 1,656.75 0 LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women 03/31/2022 INTERVENTIONAL not-comparable 1,654.75 0 IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department 03/31/2022 INTERVENTIONAL not-comparable 1,654.75 0 Assessment of Brain Cognitive Impairment in Breast Cancer 03/31/2022 OBSERVATIONAL not-comparable 1,654.75 0 Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility Study 04/04/2022 INTERVENTIONAL not-comparable 1,650.75 0 Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial 04/04/2022 INTERVENTIONAL not-comparable 1,650.75 0 Cardiac Outcomes With Near-Complete Estrogen Deprivation 04/04/2022 INTERVENTIONAL not-comparable 1,650.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology